Teva Pharmaceutical Industries

Historical 13F Holders

Symbol
TEVA
CUSIP
881624209
All holders as of
Q2 2026
Type
Equity
Class
SPONSORED ADS
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 881624209 since 12/18/2024, largest first.

Filer % of Class Filed
Migdal Insurance & Financial Holdings Ltd. 13G 5.4% 2/17/2026
Event 12/31/2025
Menora Mivtachim Holdings Ltd 13G 5.0% 7/17/2025
Event 7/16/2025
Phoenix Financial Ltd. 13G 5.0% 7/22/2025
Event 7/14/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 2 9.34 k $365 k
2026 Q2 724 780 M $26.1 B
2026 Q1 701 676 M $20.2 B
2025 Q4 714 690 M $21.5 B
2025 Q3 628 731 M $14.8 B
2025 Q2 606 754 M $12.5 B
2025 Q1 619 714 M $11.0 B
2024 Q4 646 666 M $14.6 B
2024 Q3 599 638 M $11.3 B
2024 Q2 585 628 M $10.2 B
2024 Q1 531 586 M $8.26 B
2023 Q4 496 592 M $6.22 B
2023 Q3 485 590 M $6.02 B
2023 Q2 483 499 M $3.77 B
2023 Q1 488 561 M $4.95 B
2022 Q4 474 577 M $5.26 B
2022 Q3 483 561 M $4.56 B
2022 Q2 516 507 M $3.86 B
2022 Q1 489 515 M $4.89 B
2021 Q4 512 533 M $4.28 B
2021 Q3 486 527 M $5.19 B
2021 Q2 503 561 M $5.61 B
2021 Q1 505 575 M $6.84 B
2020 Q4 525 582 M $5.72 B
2020 Q3 510 569 M $5.22 B
2020 Q2 521 582 M $7.28 B
2020 Q1 530 556 M $5.08 B
2019 Q4 517 592 M $5.81 B
2019 Q3 500 595 M $4.09 B
2019 Q2 534 654 M $6.05 B
2019 Q1 591 671 M $10.5 B
2018 Q4 637 700 M $10.8 B
2018 Q3 652 700 M $15.1 B
2018 Q2 628 674 M $16.4 B
2018 Q1 595 678 M $11.6 B
2017 Q4 595 593 M $11.2 B
2017 Q3 618 540 M $9.50 B
2017 Q2 727 591 M $19.6 B
2017 Q1 771 592 M $19.0 B
2016 Q4 816 609 M $22.1 B
2016 Q3 869 569 M $26.2 B
2016 Q2 885 597 M $30.0 B
2016 Q1 904 602 M $32.2 B
2015 Q4 956 624 M $40.9 B
2015 Q3 887 532 M $30.0 B
2015 Q2 884 516 M $30.5 B
2015 Q1 890 522 M $32.5 B
2014 Q4 887 528 M $30.3 B
2014 Q3 845 501 M $26.9 B
2014 Q2 847 508 M $26.8 B
2014 Q1 841 475 M $25.1 B